Unit:
Κατεύθυνση Διασυνδετική Ψυχιατρική και Απαρτιωμένη Φροντίδα Σωματικής και Ψυχικής ΥγείαςLibrary of the School of Health Sciences
Author:
Καλφοπούλου Κωνσταντία
Supervisors info:
Χ. Παπαγεωργίου
Original Title:
Το άγχος στους καρδιολογικούς ασθενείς που φέρουν εμφυτεύσιμες συσκευές
Summary:
Treatment of cardiac arrhythmias as the second half of the 20th century.
The evolution of technology in the electro-physiology of the heart, in the
ablation of arrhythmogenic foci and implantable cardiac rhythm management
devices brought significant advances in the areas of diagnosis and treatment of
cardiac arrhythmias.
The first pacemakers appeared in 1932. The first defibrillator was implanted in
1980 at the hospital Johns Hopkins.
Pacemakers, whose main function is the production of electrical pulses, are
monofocals or bifocals.
The bi-ventricular pacing or cardiac resynchronization therapy helps improve
heart failure. Implantable defibrillators, with powerful electric shock that
produce, restore heart function after ventricular fibrillation.
Stress, either emotional reaction or as multidimensional clinical sign or as an
expression of concern (social-economic), or behaviors event, concerns a large
part of the population with implantable devices and affects their quality of
life, as expressed - studied by a wide range of disciplines.
Typical adverse effects after implantation are anxiety, depression, panic
attacks, and fear of a possible shock, resulting in dysfunctional and social
isolation of the patient.
The interdisciplinary team approaching patients with implantable devices can
support - guide to understand the benefits of an implantable device.
Keywords:
Pacemaker, ICD, Implanted, Anxiety, Quality of life
File:
File access is restricted only to the intranet of UoA.
document.pdf
388 KB
File access is restricted only to the intranet of UoA.
